Hepatoprotective Effects of Marine Derived Bioactive Compounds against Drug Induced Liver Injury in Experimental Animals

Drug-induced liver injury (DILI) is a problem in pharmacology so marine bioactive compounds were studied as hepatoprotective candidates. This study evaluated fucoidan from brown seaweed against paracetamol liver injury in Wistar mice. The 30 male mice were divided into five groups: normal control, DILI control, comparator control receiving silymarin, and fucoidan group at doses of 100 and 300 mg/kg/day orally for 14 days. Exposure to paracetamol increased levels of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, bilirubin, and liver malondialdehyde compared to normal controls. Fucoidan at a dose of 300 mg/kg reduced ALT and AST by 35% and 31%, respectively, and improved liver antioxidant and histological status compared to the DILI control. These findings show the potential of fucoidan in protecting the liver and require further research related to its pharmacology and safety.

Authors

Institutions

Publication Details

Journal
Public Health Journal
Published
2026-11-15
DOI
https://doi.org/10.62710/2a3pcv48
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hepatoprotective Effects of Marine Derived Bioactive Compounds against Drug Induced Liver Injury in Experimental Animals

Adi Setiadi
Public Health Journal
Drug-Induced Hepatotoxicity and Protection
article

Hepatoprotective Effects of Marine Derived Bioactive Compounds against Drug Induced Liver Injury in Experimental Animals

Adi Setiadi
article en

Abstract

Drug-induced liver injury (DILI) is a problem in pharmacology so marine bioactive compounds were studied as hepatoprotective candidates. This study evaluated fucoidan from brown seaweed against paracetamol liver injury in Wistar mice. The 30 male mice were divided into five groups: normal control, DILI control, comparator control receiving silymarin, and fucoidan group at doses of 100 and 300 mg/kg/day orally for 14 days. Exposure to paracetamol increased levels of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, bilirubin, and liver malondialdehyde compared to normal controls. Fucoidan at a dose of 300 mg/kg reduced ALT and AST by 35% and 31%, respectively, and improved liver antioxidant and histological status compared to the DILI control. These findings show the potential of fucoidan in protecting the liver and require further research related to its pharmacology and safety.

Public Health JournalVol. 3(4)
Universitas Bina Bangsa (ID)
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon